Our Team
Our dynamic and dedicated team is at the forefront of innovation in the field of anti-viral, anti-fungal, and anti-bacterial treatments. Comprised of experienced leaders and passionate researchers, we are committed to pioneering new solutions that promote health and well-being. With a shared vision for excellence and a relentless drive for discovery, we work collaboratively to push the boundaries of pharmaceutical research and deliver impactful solutions to combat infectious diseases. Together, we are shaping the future of healthcare through our unwavering dedication and innovative spirit.
Geoff Lee
CEO
Geoff Lee has over 20 years of experience in the biotechnology, functional health & wellness products and data technology sectors. He has been involved in the co-founding, managing, operating and commercial scale-up, capital raising and corporate governance of businesses in these sectors. Mr. Lee is a co-founder of Functional Technologies Corp. (Canada) and Phyterra (USA), the predecessor companies of what is now Renaissance Bioscience Corp. Geoff has served as a director and/or officer in, both, private and public companies. He received his M.B.A. from the Ivey Business School.
Jay Dhaliwal
Director
Jay Dhaliwal is a registered pharmacist, CEO and director of multiple publicly traded companies listed in Canadian (CSE, TSX) and American (Nasdaq) exchanges. Mr. Dhaliwal is currently a director of a leading seed to patient cannabis producer based out of Europe and currently listed on the Nasdaq. In addition, he is an independent director of a Nasdaq listed premier marketing agency specialized in the liquor industry. He was previously CEO of a large retail cannabis operation, giving him an in depth knowledge at dealing with government agencies associated with liquor and cannabis boards. He has worked in an upper management role in a large national banner pharmacy utilizing his skills to drive growth at the consumer level and savings through supply chain negotiations. He has extensive knowledge in agricultural, medical, and pharmaceutical operations. Mr. Dhaliwal has overseen the acquisition and development of numerous projects, technology platforms and applications. He has overseen operations of numerous retail and commercial operations and implemented various health protocols and technology advances into health and wellness chains. Jay holds a Bachelor of Pharmacy from the University of British Columbia and a Bachelor of Science in biology from the University of Victoria.
Nick Radojevic
Advisor
Nick brings over 25 years of pharmaceutical and biotechnology experience within R&D and Medical Affairs. He has been involved in multiple product launches of novel pharmaceutical therapies in a variety of medical areas including, rheumatology, dermatology, urology, and most recently in IBD with Abbvie. His nearly 20 years in medical affairs allowed him to be an integral member of pre-launch, commercialization, and post launch teams, critically involved in all aspects of drug development, positioning, and approval. More specifically, this includes clinical development, data analysis, publications, regulatory submissions, marketing strategy, market access presentations, and sales/MSL training. Mr. Radojevic excels in developing peer to peer scientific relationships with research minded physicians resulting in high quality scientific advisory and partnership of developing assets. In addition to his extensive work in medical affairs, he has also managed over 75 registrational phase II/III trials, including investigator initiated trials during his time in clinical operations / clinical development. Nick completed his M.Sc. degree at McMaster University in MIVI (molecular immunology, virology, and inflammation) under Dr. Stephen Collins focusing on immune mediated mechanisms associated with IBS/IBD.
Marek Jasinski
Marek Jasinski, a founding member of NAVCO Pharmaceuticals, boasts over two decades of leadership experience in multiple technology-driven start-ups that have generated substantial revenue. His comprehensive expertise encompasses artificial intelligence, quantum mechanics, nanotechnology, and biotechnology. Mr. Jasinski excels in translating complex scientific principles into ground-breaking commercial solutions. At NAVCO, he is pioneering technologies to transform the health sciences through innovative nanoparticle-based methods. By leveraging innovative approaches to align medicinal substances with new methods of action, Marek is redefining the application of medical nanoparticles and broadening the company’s reach in the pharmaceutical and wellness industries.
Director, Founding Member & COO
Tom Jusdanis
Director
Thomas Jusdanis has a broad range of business skills with extensive, executive and management experience, from R&D, industrial development, restaurant operations and retail telecom industry for one the largest companies in Canada. Mr. Jusdanis was the corporate secretary and director of a reporting issuer in Ontario for a start-up R&D company in the forefront of data transfer technology in the 80’s. The company then transitioned into a 400,000 sq ft industrial property ownership and management. Tom went on to become President of a very successful internet start-up focusing a searchable online database of unclaimed assets. He was involved from its infancy when it started with a pay per call multi-line 900 service. The company soon expanded onto the Internet where no such online searchable database existed for unclaimed assets, generating millions of online searches.
Judy Su
Director
Judy Su was lead pharmacist at a national drug store for four years and has a vast understanding of large-scale retail distribution of scheduled drugs and medications. Currently, Ms. Su works as a pharmacist in the public sector, where she is instrumental in pharmaceutical practices of the province. Judy graduated in 2012 at the University of British Columbia with bachelor’s degree in pharmacy.
Chris Cooper
CFO
Chris Cooper has over 20 years of extensive business experience in all facets of corporate development, senior management, finance and operations, in both the private and public sectors. Mr. Cooper’s experience includes spearheading growth strategies, financial reporting, quarterly and annual budgets, overseeing corporate administration, while achieving company objectives and maintaining internal cost controls. Chris has held a Director position in several private and public companies over the past 20 years. He received his Bachelor of Business Administration from Hofstra University and his M.B.A. from Dowling College in New York.